Presentation is loading. Please wait.

Presentation is loading. Please wait.

Robert Nataf M.D. Laboratoire Philippe Auguste Avenue Philippe Auguste

Similar presentations


Presentation on theme: "Robert Nataf M.D. Laboratoire Philippe Auguste Avenue Philippe Auguste"— Presentation transcript:

1 Improvement in biological indicators in Autism: properly define clinical improvement
Robert Nataf M.D. Laboratoire Philippe Auguste Avenue Philippe Auguste Paris France Tel: (33) Fax: (33) Laboratoire Philippe Auguste

2 Detoxification system
Nervous system Malnutrition Neuro-inflammation Environment Autism Toxins Oxidative Stress GI system Immune system Genomes Detoxification system Laboratoire Philippe Auguste

3 Biochemical Abnormalities in Autism
Elevated toxic metals and Xenobiotics Immune Disorder Severe oxidative stress & damage Laboratoire Philippe Auguste

4 Urinary Porphyrins: A Biomarker of Environmental Toxicity
Laboratoire Philippe Auguste

5 What are the porphyrins?
Porphyrins are cruciform compounds (4 Pyrroles) synthesized by all the cells of the living organism which constitute the active sites of the hemoproteins which transport oxygen Hb & Mb, ensure the energy production Cytochromes A3, B, C and the detoxication of xenobiotic, Cytochromes P450. Laboratoire Philippe Auguste

6 PORPHYRINS SYNTHESIS 8 enzymes ensures in mitochondrion and cytoplasm, the synthesis of porphyrins: It may be divided into 3 steps : reaction of 2 simple molecules, glycine (from the general amino acid pool) and succinyl-CoA (from the tricarboxylic acid cycle) to Porphobilinogen. Decarboxylation reaction from Uroporphyrin (8-carboxy) to Coproporphyrin (4-carboxy). 3. The synthesis of heme from 2-carboxyporphyrin through two last biosynthetic pathway enzymes. Laboratoire Philippe Auguste

7 Heme biosynthetic pathway
M.W. 742 M.W. 830 M.W. 786 M.W. 566 M.W. 698 1 = d-aminolevulinicacid (ALA) synthetase 2 = ALA dehydratase 3 = uroporphyrinogen I synthetase PBGD 4 = uroporphyrinogen III cosynthetase 5 = UROD (Uroporphyrinogen decarboxylase) 6 = COPOX (Coproporphyrinogen oxidase) 7 = Protoporphyrinogen oxidase 8 = Ferrochelatase Heme biosynthetic pathway Laboratoire Philippe Auguste

8 Toxic sensitivity of different porphyrins
Polychorinated Biphenyl (PCB) UroP Arsenic (As) cxP Aluminium (Al) Mercury (Hg) cxP PcP CoP Lead (Pb) CoP COP-O COP-OX URO-D URO-D URO-D Heme Laboratoire Philippe Auguste URO-D = Uroporphyrin Decarboxylase COP-O Coproporphyrin oxidase

9 Xenobiotics target in Heme biosynthetic pathway at 3 sides
- + + - - glycine - ALA-S CPOX 8-CP 6-CP 7-CP 5-CP 4-CP 2-CP ALA SUCC Heme Laboratoire Philippe Auguste

10 Xenobiotic compounds Laboratoire Philippe Auguste

11 Aluminium (Al) Laboratoire Philippe Auguste

12 Arsenic (As) Laboratoire Philippe Auguste

13 3 ENZYMES OF THE HEME BIOSYNTHETIC PATHWAY
LEAD TARGETS 3 ENZYMES OF THE HEME BIOSYNTHETIC PATHWAY Laboratoire Philippe Auguste

14 5-Amino-levulinate (ALA)
Kreb Cycle HEME 49911 1334 Succinyl-CoA Protoporphyrinogen Pb 23137 Glycine 1333 5-Amino-levulinate (ALA) Coproporphyrinogen 42124 41137 4318 Porphobilinogen Uroporphyrinogen 42175 Laboratoire Philippe Auguste

15 PORPHYRIN BIOSYNTHETIC PATHWAY PROVIDES 3 MARKERS OF LEAD TOXICITY
Targeted Enzymes Biological Markers ALA DEHYDRATASE  2nd==> ALA (5 Amino Levulinic Acid) in urine and plasma COP-OXIDASE     6th enz  ==> COPROPORPHYRINE in urine (lack of specifcity) HEME SYNTHASE  8th enz==>  PROTOPORPHYRIN & ratio PP/HEME in blood erythrocytes Laboratoire Philippe Auguste

16 Lead (Pb) Laboratoire Philippe Auguste

17 UROPORPHYRIN DECARBOXYLASE
POSSESSES 4 DISTINCT SITES OF DECARBOXYLATION Hg inhibits only the 4th site of decarboxylation generating accumulation 5CXP UROPORPHYRIN DECARBOXYLASE (MW 80000) 1st site 2nd site 3rd site 4th site -CO2 -CO2 -CO2 -CO2 6-carboxy-P 5-carboxy-P 4-carboxy-P or Copro-P 8-carboxy-P or Uro-P 7-carboxy-P Laboratoire Philippe Auguste

18 Mercury targets CPOX and UROD in Heme biosynthetic pathway
Hg UROD CPOX 8-CP 7-CP 6-CP 5-CP 4-CP 2-CP Heme CPOX4 KICP Promotion in presence of Hg James S. Woods et al.. Texicology Letter 2005…. Laboratoire Philippe Auguste

19 Mercury (Hg) Laboratoire Philippe Auguste

20 Moderate Hg toxic effect
WO JA Age = 3 Moderate Hg toxic effect Urinary Hg = µg/l = µg/gCr PCP/URO = 1 5CXP >7CXP COP increased Laboratoire Philippe Auguste

21 Moderate Hg toxic effect
Urinary Hg = µg/l = µg/gCr PCP/URO = 1 5CXP > 7CXP association? Uncoupled COP Laboratoire Philippe Auguste

22 Noticeable Hg toxic effect
NI AN Noticeable Hg toxic effect Age = 5 Urinary Hg = 0.11 µg/gCr PCP = 1. 3 URO 5CXP > 7CXP = 1.5 increased COP Laboratoire Philippe Auguste

23 High and exclusive Hg toxic effect
WE RI Age = 4 Urinary Hg = µg/l = µg/gCr High and exclusive Hg toxic effect High PCP/URO > 4 PCP/5CXP > 5 5CXP/7CXP > 2, repression URO level and Por Synth Rate ? Laboratoire Philippe Auguste

24 High Hg toxic effect SO KE PCP twice higher URO 5CXP > 7CXP
Age = 3 Urinary Hg = µg/gCr High Hg toxic effect PCP twice higher URO 5CXP > 7CXP high COP xenobiotics ? lead ? Laboratoire Philippe Auguste

25 Estonian child with MENTAL RETARDATION
SA SA Estonian child with MENTAL RETARDATION Urinary Hg = 1.06 µg/gCr Age = 2 probably no up regulated porphyrin synthesis but polyhalogenated uro-D inhibition, and increased Hg specific porphyrins Laboratoire Philippe Auguste

26 High Hg toxic effect Xenobiotics
ZH SA High Hg toxic effect Xenobiotics Age = 2 Urinary Hg = µg/gCr Up-regulation porphyrin synthesis PCP twice higher URO 5CXP > 7CXP high COP Laboratoire Philippe Auguste

27 brothers Laboratoire Philippe Auguste

28 Twin Brothers Laboratoire Philippe Auguste

29 Parents Laboratoire Philippe Auguste

30 High Hg Toxicity Laboratoire Philippe Auguste

31 04/07/07 17/12/07 precopro precopro Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

32 14/11/07 02/01/08 Pre-Chelation Post-Chelation
Laboratoire Philippe Auguste

33 25/04/07 29/11/07 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

34 12/11/07 08/06/07 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

35 20/06/07 12/10/07 Pre-Chelation Post-Chelation
Laboratoire Philippe Auguste

36 20/06/07 12/10/07 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

37 20/06/07 12/10/07 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

38 Post-Chelation Pre-Chelation 10/07 12/07 Laboratoire Philippe Auguste

39 26/07/07 02/11/07 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

40 12/11/07 15/06/07 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

41 01/06/07 13/11/07 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

42 22/08/07 18/12/07 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

43 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

44 Porphyrinuria in childhood autistic disorder, Implication for environmental Toxicity
Toxicology and Applied Pharmacology (June, 2006) Nataf R, Skorupka C, Amet L, Lam A, Springbett, Lathe R, Laboratoire Philippe Auguste

45 269 Study Subjects ( ) Laboratoire Philippe Auguste

46 Coproporphyrin levels in urines of children with neurodevelopmental and related disorders
CTRL 2 x SD CTRL MEAN Laboratoire Philippe Auguste

47 Elevated urinary Coproporphyrin (COPRO) levels in ASD expressed as absolute values normalised to creatinine (left) or as an internal ratio with uroporphyrin (URO) (right) Laboratoire Philippe Auguste

48 Precoproporphyrin and pentacarboxy porphyrin: Markers of heavy metal toxicity
Control ASP AUT AUT +EPI (1.28) (1.09) (0.62) (0.56) uroporphyrin Precoproporphyrin plotted against baseline uroporphyrin : the ratio is independent of age-related creatinine variation Laboratoire Philippe Auguste

49 Spectrum of mean porphyrin excess, expressed as a ratio of control group (CTL) value for the different porphyrin subtypes Laboratoire Philippe Auguste

50 Neopterin Marker of Neuroinflammation
Neuroinflammation in Autism Laboratoire Philippe Auguste

51 Neuroinflammation appears as a prominent histological feature in brain regions affected by autism.
Mediated by virus vaccine or infectious agents or other factors, neuroinflammation is largely cytokine dependent. Neopterin, which is a central plate form and a common final pathway in cytokine production and activity, is regarded as an index of inflammation associated immune activation. Synthesized through the same teleonomic pathway, reduced Biopterin (BH4), alleviates oxidative damage issued from neopterin induced immune activation. Laboratoire Philippe Auguste

52 Laboratoire Philippe Auguste

53 Upon stimulation with the Th1 cell-derived cytokine interferon-g, human macrophages produce neopterin, a 2-amino-4-hydroxy-6-(D-erythro- 1´,2´, 3´-tryhydroxypropyl)-pteridine. Besides, macrophages also release reaktive oxygen species (ROS) and tumor necrosis factor-a (THF-a). Laboratoire Philippe Auguste

54 Neopterin Laboratoire Philippe Auguste

55 Laboratoire Philippe Auguste

56 Biopterin is Neopterin’s antidote.
If Neopterin is constantly increased in autism, Biopterin is most frequently diminished.  The enlarged differential between these two pterins could be considered as an index of deleterious consequences of inflammation. Laboratoire Philippe Auguste

57 Urinary Neopterine in Autism in 110 Children
(Age between 2-11 years old) nmole/mmole Cr 600 500 400 Neopterine n=159 300 200 100 n=32 Autism Control 515 207 220126 Laboratoire Philippe Auguste

58 20/06/07 12/10/07 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

59 Post-Chelation Pre-Chelation 10/07 12/07 Laboratoire Philippe Auguste

60 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

61 Oxidative Stress in Autism
Laboratoire Philippe Auguste

62 Is oxidative stress increased in Autism ?
Underlying reasons :: Neuroinflammation, Infectious processes, Mercury oxidative injury Gene-Environment interaction issued metabolic imbalance. If so, assessment should turn to brain damaging oxidative markers recently highlighted in neurodegenerative diseases. In preliminar results in our laboratory, children  suffering from ASD, exhibit elevated urinary 8-oxo-guanosine(8OHG), RNA oxidation by-product, twice higher than in sibling controls. Laboratoire Philippe Auguste

63 Laboratoire Philippe Auguste

64 Laboratoire Philippe Auguste

65 8-Oxo-Deoxyguanosine (8OHdG)
(DNA damage) Laboratoire Philippe Auguste

66 Laboratoire Philippe Auguste

67 8-oxo-deoxyguanosine (8OHdG) 8-oxo-guanosine (8-OHG)
Laboratoire Philippe Auguste

68 Main pathologies related to 8-oxo-DeoxyGuanosine increase
Laboratoire Philippe Auguste

69 Main pathologies related to 8-oxo-Guanosine increased
brain degenrative diseases Lateral Amyotrophic Sclerosis Alzheimer Disease 8-oxo-guanosine RNA oxidative damage marker to asses oxidative stress Senile Dementia Parkinson Disease Laboratoire Philippe Auguste

70 Senile Dementia with lewy bodies
RNA oxidation is an early and prominent feature of main brain neurodegenerative diseases AD PD Senile Dementia with lewy bodies ALS MSA-PD In AD cytoplasmic RNA oxidation by free radicals released by mitochondria is an early event of perikaryon degeneration precessing specific neurofibrillar tangles . Laboratoire Philippe Auguste

71 Is cytoplasmic RNA oxidation a mitochondria’s failure consequence ?
Laboratoire Philippe Auguste

72 DNA and RNA Oxidative Markers preliminary results in 110 Children
(Age between 2-11 years old) nmole/gCr 8733 Autism 100 4327 Control 50 3513 29 11 Autism Control 8OHdG 8OHG Laboratoire Philippe Auguste

73 20/06/07 12/10/07 Post-Chelation Pre-Chelation
Laboratoire Philippe Auguste

74 Environment Intoxication? Structure Modification
Inflammation Stress Oxydant Function Loss Genetic Pathogenic Interactions in Autism?? Laboratoire Philippe Auguste

75 Using Urinary Porphyrin, Neopterin and 8OHdG/8OHG Profile In Chelation Therapy
Laboratoire Philippe Auguste

76 Urinary Porphyrin profile attests the effectiveness of Chelation Therapy, displaying the reduction of Mecury Responsive Metabolites 5-carboxyporphyrins, Precoproporphyrins, Coproporphyrins and often total Porphyrinuria. It helps to determine when a patient is cleaned up from their body burden of toxicities. Laboratoire Philippe Auguste

77 n=190 age = 1-12 years old Pre-chelation Post-chelation
Laboratoire Philippe Auguste

78 n=190 age = 1-12 years old Pre-chelation Post-chelation
Laboratoire Philippe Auguste

79 n=190 age = 1-12 years old Pre-chelation Post-chelation
Laboratoire Philippe Auguste

80 As the same time decrease inflammation, as shown by reduction in macrophage activation issued Neopterins. Laboratoire Philippe Auguste

81 And decreaseoxidative stress , inside nucleus and through cytoplasm, as shown by 8-oxo-Deoxyguanosine (8OHdG) and 8-oxo-Guanosine(8OHG) reduction. Laboratoire Philippe Auguste

82 Thank you Laboratoire Philippe Auguste


Download ppt "Robert Nataf M.D. Laboratoire Philippe Auguste Avenue Philippe Auguste"

Similar presentations


Ads by Google